Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
CAMBRIDGE, Mass., Dec. 24, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the expansion of its integrated discovery and development framework to support early clinical development and Investigator-Initiated Trials (IITs). This expansion extends Nona's capabilities beyond discovery and IND-enabling activities to further strengthen...
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101’ on Gastric Cancer.
SEONGNAM, South Korea, Dec. 24, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API: SN-38) which is a polymer nanoparticle drug under phase 1b/2 clinical trial for small cell lung cancer. SNB-101 is the world's...
NAVER D2SF-Backed Startups Participate in “CES 2026”
Five teams won CES Innovation Awards, including one Best of Innovation Award and three double Innovation Award winners Proving technological capabilities on the global stage across diverse sectors, including mobility, vertical AI, and healthcare Over 80% of portfolio companies targeting global markets, strengthening NAVER D2SF's role as a launchpad for Korean startups SEOUL, South Korea, Dec. 24,...
Puainta Smashes Black Friday Records and Marks Successful Entry into UK Market
LOS ANGELES, Dec. 24, 2025 /PRNewswire/ -- Puainta, a rapidly growing innovator in pet healthcare and wellness, today announced significant milestones following the 2025 Black Friday sales event. The brand reported an unprecedented surge in global sales, a successful strategic expansion into the UK market, and strengthened partnerships with leading animal rescue organizations, solidifying its position as a trusted...
Bridging the “Last Mile” of Medical Innovation: ICMIS 2025 Successfully Concludes with Capital and Industry Collaborating to Accelerate Commercialization
HONG KONG, Dec. 23, 2025 /PRNewswire/ -- In the current global MedTech landscape, technological breakthroughs are only the starting point. The real measure of scientific research is whether laboratory discoveries can be translated into safe, effective, and widely used clinical products. Yet the development of medical technology is often complex and challenging. In an increasingly rational market environment, constructing sustainable...
Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued progress across its AI-enabled drug development platform at its 2025 annual investor conference, reinforcing its strategic position...
Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy
DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein in Cell Reports Medicine. The peer-reviewed article details the preclinical and translational validation of FP008 (anti-PD-1 × IL-10M)....
MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi
KARACHI, Pakistan, Dec. 23, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat (KPSIAJ) announced the signing of a landmark Memorandum of Understanding (MOU) establishing a strategic collaboration to introduce responsible, community-centered AI innovation across KPSIAJ's education and healthcare ecosystem. Under this agreement, MindHYVE.ai™ will support KPSIAJ in deploying...
TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year
TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking its third consecutive year of recognition. The award honors TraceLink's continued leadership in transforming the life sciences and healthcare supply chain through OPUS—its industrial no-code platform that powers agentic supply chain orchestration across a global network...
MCB Group Unveils Daily Sports Nutrition Innovations at SupplySide Global 2025, Spotlighting Creatine, MCT, and Plant-Based Protein
TAIPEI, Dec. 22, 2025 /PRNewswire/ -- MCB Group, a Taiwan-based global manufacturer of premium nutritional powder ingredients, has further streamlined its operations into a full CDMO private-label provider, showcasing a range of trend-driven branded ingredients and turnkey total solutions at SupplySide Global 2025, aimed at capturing growth in next year's booming market. MCB Group...
